Disturbance of sleeping cycle: High doses of glutathione may result in irregular sleep and restlessness
For non-diabetic patients exploring GLP-1 therapy, understanding both your biomarkers (glucose, insulin, lipids) and your genetic context can support a more confident, evidence-informed discussion with your provider about whether this treatment approach is appropriate for you and what outcomes to expect
I have a more conservative approach
In September, Lilly and Boehringer released a batch of real-world data showing Jardiance pared down the risk of heart failure hospitalizations by 26% over GLP-1 agonists
MDA, malondialdehyde
References: Jett L, Lger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, Paradis V, van Wyk P, Pham K, Bridon DP